Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Taro-Fingolimod, Capsules
Product Information
-
DIN:02469618
-
Active Ingredients :fingolimod
-
Innovator Name:Gilenya ®
-
Dosage form:Capsule
-
Strength:0.5 mg
-
Route of Administration:Oral
-
Colour:white / yellow
-
Markings:"064" in black ink
- Package size:
28 Blister - UPC Code:
063691084339 -
Description :capsules have a white body and yellow cap; axially imprinted with “064” on cap and on body in black ink, filled with white to off-white powder
-
Non-medicinal ingredients :Polacrilin potassium, crospovidone, colloidal silicon dioxide, magnesium stearate, capsule shell contain: gelatin, titanium dioxide, yellow iron oxide, sodium lauryl sulphate. Non-volatile components of black ink: shellac, propylene glycol, black iron oxide and potassium hydroxide
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here